Table of Contents:
  • Prognostic biomarkers in breast cancer
  • Microsatellite instability (MSI) in colon cancer
  • Markers for metastatic germ cell cancers
  • Systemic treatments for cancer therapies
  • Therapy predictive markers
  • Toxicity markers
  • Determining treatment effectivity
  • Caveats in use of markers in therapy
  • Current vs. future approach to cancer management